Testing Endurance

Researchers follow 44 ultramarathon runners in a race across Europe to track the body's response to extreme physical challenge.

By | July 26, 2012


During the Trans Europe Foot Race, runners cover more than 4,487 kilometers (2,788 miles) from southern Italy to North Cape, Norway. For the 2009 race, 44 of those runners submitted to daily health examinations, including MRI scans with a mobile scanner, ice-water pain tests, and blood and urine analyses. The project, detailed last week (July 19) in BioMed Medicine, was divided into four modules:

  • Musculoskeletal system: to investigate potential damage to joints, bones, and soft tissues in the legs
  • Brain, mind, and pain perception: to investigate changes in the volume of the brain, damage caused by lesions, pain perception, and mental stress
  • Cardiovascular system: to assess the effects of stress on the heart and arterial wall strength
  • Body composition: to track changes in muscle mass and body fat
While the huge resulting data set is still being looked at from every angle, the researchers have released some preliminary results. Of studied runners that didn't finish the race, the most common reason was inflammation of the leg tissues due to overuse. Two runners fractured bones, but because of their high pain tolerance, they ran over 200 more kilometers before giving up. Some runners who experienced leg inflammation were able to continue running, and it eventually cleared up.

The data will be used to assess the course of breakdown and regeneration in such injuries, as well as provide insights into the susceptibility to injury between individuals. By looking into the brain, the researchers also hope to investigate the hormonal influence resulting from endurance exercise.

"This pioneering study will assess the impact of extreme endurance on human physiology," wrote Andrew Murray and Ricardo Costa in an editorial for BioMed Medicine. "The results will be of interest not only to endurance runners, but to anyone interested in the limits of human performance."

Correction (July 30, 2012): This story has been updated from its original version to correctly reflect the journal name as BioMed Medicine, not BioMed Central Medicine. The Scientist regrets the error.

Add a Comment

Avatar of: You



Sign In with your LabX Media Group Passport to leave a comment

Not a member? Register Now!

LabX Media Group Passport Logo

Popular Now

  1. UC Berkeley Receives CRISPR Patent in Europe
    Daily News UC Berkeley Receives CRISPR Patent in Europe

    The European Patent Office will grant patent rights over the use of CRISPR in all cell types to a University of California team, contrasting with a recent decision in the U.S.

  2. DNA Replication Errors Contribute to Cancer Risk
  3. Should Healthy People Have Their Exomes Sequenced?
    Daily News Should Healthy People Have Their Exomes Sequenced?

    With its announced launch of a whole-exome sequencing service for apparently healthy individuals, Ambry Genetics is the latest company to enter this growing market. But whether these services are useful for most people remains up for debate.  

  4. Rethinking a Cancer Drug Target
    Daily News Rethinking a Cancer Drug Target

    The results of a CRISPR-Cas9 study suggest that MELK—a protein thought to play a critical role in cancer—is not necessary for cancer cell survival.

Business Birmingham